13-cis-retinoic acid,Isotretinoin

13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.

Cross Reference

Introduction

To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 13-cis-retinoic acid,Isotretinoin?

13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin

MeSH term MeSH ID Detail
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Acne Vulgaris D000152 35 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Lung Neoplasms D008175 171 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 13-cis-retinoic acid,Isotretinoin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 13-cis-retinoic acid,Isotretinoin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

What genes are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 13-cis-retinoic acid,Isotretinoin

Download all related citations
Per page 10 20 50 100 | Total 2952
Authors Title Published Journal PubMed Link
Hsu CW et al. Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor. 2014 Sci Rep pmid:25257666
Kaplan R et al. A case of isotretinoin-induced purpura annularis telangiectodes of Majocchi and review of substance-induced pigmented purpuric dermatosis. 2014 JAMA Dermatol pmid:24284887
Pinto N et al. Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation. 2014 Pediatr Blood Cancer pmid:24293072
Sikar Aktürk A et al. The effects of isotretinoin on the ovarian reserve of females with acne. 2014 Gynecol. Endocrinol. pmid:24256373
Racine A et al. Isotretinoin and risk of inflammatory bowel disease: a French nationwide study. 2014 Am. J. Gastroenterol. pmid:24535094
Giavedoni P et al. Acne fulminans successfully treated with cyclosporine and isotretinoin. 2014 J. Am. Acad. Dermatol. pmid:24438977
Cheung NK et al. Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma. 2014 Int. J. Cancer pmid:24644014
Hamoudi MC and Bochot A Oil-cyclodextrin based beads for oral delivery of poorly-soluble drugs. 2014 Curr Top Med Chem pmid:24354669
Tenner S Isotretinoin and inflammatory bowel disease: trial lawyer misuse of science and FDA warnings. 2014 Am. J. Gastroenterol. pmid:24698863
Sonawane P et al. Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma. 2014 Br. J. Pharmacol. pmid:25039756
Gusenleitner D et al. Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action. 2014 PLoS ONE pmid:25058030
Chen SE et al. Isotretinoin maintenance therapy for glioblastoma: a retrospective review. 2014 J Oncol Pharm Pract pmid:23676507
Marrouche N et al. Pityriasis rubra pilaris: clinicopathological study of 32 cases from Lebanon. 2014 Int. J. Dermatol. pmid:24783259
Sardana K and Garg VK Antibiotic resistance in acne: is it time to look beyond antibiotics and Propionobacterium acnes? 2014 Int. J. Dermatol. pmid:24738843
Gollnick HP and Zouboulis CC Not all acne is acne vulgaris. 2014 Dtsch Arztebl Int pmid:24828100
Lamb RC et al. Avascular necrosis of the hip and diffuse idiopathic skeletal hyperostosis during long-term isotretinoin treatment of epidermolytic ichthyosis due to a novel deletion mutation in KRT10. 2014 Br. J. Dermatol. pmid:24720725
Tauber M et al. Unresectable perineal cuniculatum carcinoma: partial remission using systemic isotretinoin and interferon-α2a therapy. 2014 Acta Derm. Venereol. pmid:24676771
Fernández-Crehuet P et al. Hepatotoxicity of isotretinoin in patients with acne and Gilbert's syndrome: a comparative study. 2014 BMJ Open pmid:24650805
Lagan BM et al. Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies. 2014 Pharmacoepidemiol Drug Saf pmid:24493556
Noh S et al. A case of sebaceous hyperplasia maintained on low-dose isotretinoin after carbon dioxide laser treatment. 2014 Int. J. Dermatol. pmid:23621277
Aguilar S et al. Congenital neuroblastoma in a neonate with isotretinoin embryopathy. 2014 J. Pediatr. Hematol. Oncol. pmid:23652876
Miller IM et al. Infantile acne treated with oral isotretinoin. 2013 Sep-Oct Pediatr Dermatol pmid:23278140
On SC and Zeichner J Isotretinoin updates. 2013 Sep-Oct Dermatol Ther pmid:24099068
Tan J and Knezevic S Improving bioavailability with a novel isotretinoin formulation (isotretinoin-Lidose). 2013 Sep-Oct Skin Therapy Lett. pmid:24305729
Kiratli H and Dikmetaş Ö Bilateral lacrimal gland enlargement associated with isotretinoin treatment. 2013 Nov-Dec Ophthal Plast Reconstr Surg pmid:23511995
Geller AS and Alagia RF Sacroiliitis after use of oral isotretinoin--association with acne fulminans or adverse effect? 2013 Nov-Dec An Bras Dermatol pmid:24346917
Sarici D et al. Asymmetric crying face in a newborn with isotretinoin embryopathy. 2013 Nov-Dec Pediatr Dermatol pmid:22612313
Scheinfeld N ABSORICA (isotretinoin): a new form. 2013 Mar-Apr Skinmed pmid:23745231
Topal IO et al. Generalized lichen nitidus: successful treatment with systemic isotretinoin. 2013 Jul-Aug Indian J Dermatol Venereol Leprol pmid:23760340
Santos-Pérez MI et al. [Suspicion of diabetes mellitus isotretinoin-induced]. 2013 Jul-Aug Farm Hosp pmid:24010698
Preneau S et al. Predictive markers of response to isotretinoin in female acne. 2013 Jul-Aug Eur J Dermatol pmid:23797561
Digiovanna JJ et al. Systemic retinoids in the management of ichthyoses and related skin types. 2013 Jan-Feb Dermatol Ther pmid:23384018
Nevoralová Z and Dvořáková D Mood changes, depression and suicide risk during isotretinoin treatment: a prospective study. 2013 Int. J. Dermatol. pmid:23347302
Sekeryapan B et al. Retinal nerve fiber layer and ganglion cell layer thickness in patients receiving systemic isotretinoin therapy. 2013 Int Ophthalmol pmid:23338233
Silva FS et al. The in vitro and in vivo genotoxicity of isotretinoin assessed by cytokinesis blocked micronucleus assay and comet assay. 2013 Toxicol In Vitro pmid:23318729
Güngör S and Gökdemir G Anal fissure and rectal bleeding as a complication of systemic isotretinoin therapy: dermatologists know this side-effect, what about proctologists? 2013 Colorectal Dis pmid:23701373
Abali R et al. Decreased ovarian reserve in female Sprague-Dawley rats induced by isotretinoin (retinoic acid) exposure. 2013 Reprod. Biomed. Online pmid:23768617
Marron SE et al. Anxiety, depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin. 2013 Acta Derm. Venereol. pmid:23727704
Silva FS et al. The antiestrogen 4-hydroxytamoxifen protects against isotretinoin-induced permeability transition and bioenergetic dysfunction of liver mitochondria: comparison with tamoxifen. 2013 J. Bioenerg. Biomembr. pmid:23779226
Alzoubi KH et al. The effect of genetic polymorphisms of RARA gene on the adverse effects profile of isotretinoin-treated acne patients. 2013 Int J Clin Pharmacol Ther pmid:23782583
Segaran A et al. Pyoderma gangrenosum arising in a breast reduction scar: seven years post-procedure. 2013 J Plast Reconstr Aesthet Surg pmid:23759719
Manders KC et al. [Pregnancy after isotretinoin use]. 2013 Ned Tijdschr Geneeskd pmid:24103139
Yılmazer B et al. Bilateral acute sacroiliitis due to isotretinoin therapy: a case report. 2013 Int J Rheum Dis pmid:24164852
Fain K and Alexander GC Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. 2013 Pharmacoepidemiol Drug Saf pmid:24115318
Oepkes D [Never give negative pregnancy advice]. 2013 Ned Tijdschr Geneeskd pmid:24330800
Sung KW et al. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study. 2013 Bone Marrow Transplant. pmid:22635247
Dubeau MF et al. Drug-induced inflammatory bowel disease and IBD-like conditions. 2013 Inflamm. Bowel Dis. pmid:22573536
Kaptanoglu AF et al. Effect of isotretinoin on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT). 2013 J Dermatolog Treat pmid:22188511
Ustun I et al. Gynecomastia: a rare complication of isoretinoin? 2013 Cutan Ocul Toxicol pmid:22813063
Femia AN and Ann Vleugels R Toward improved understanding of a potential association between isotretinoin and inflammatory bowel disease. 2013 J. Invest. Dermatol. pmid:23486427